Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Executive Order Reduces Childhood Vaccine Recommendations
In today's Pharmaceutical Executive Daily, a new report finds U.S. rare disease biotech investment rebounding after FDA's Priority Review Voucher pro…
3 months, 1 week ago
Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience
In today's Pharmaceutical Executive Daily, Jazz Pharmaceuticals agrees to acquire Actio Biosciences, Novo Nordisk, Innate Pharma, and Innovent Biolog…
3 months, 1 week ago
Pharmaceutical Executive Daily: Amazon Pharmacy to Offer GLP-1 Delivery Service
In today's Pharmaceutical Executive Daily, Amazon Pharmacy launches a GLP-1 delivery service for eligible Medicare patients, Tarsus Pharmaceuticals a…
3 months, 1 week ago
Pharmaceutical Executive Daily: FDA Approves Orezeyful
In today's Pharmaceutical Executive Daily, an antitrust attorney weighs the legal risks of a hypothetical AstraZeneca-Bristol Myers Squibb merger, El…
3 months, 1 week ago
Pharmaceutical Executive Daily: Source Denies AstraZeneca-Bristol Myers Squibb Merger Talks
In today's Pharmaceutical Executive Daily, a senior source denies reports of merger talks between AstraZeneca and Bristol Myers Squibb, CSPC Pharmace…
3 months, 1 week ago
Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals
In today's Pharmaceutical Executive Daily, Pathos AI signs licensing deals with Alphamab Oncology and AstraZeneca while Curium agrees to acquire Lant…
3 months, 2 weeks ago
Pharmaceutical Executive Daily: AstraZeneca and Bristol Myers Squibb Held Merger Talks
3 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data
In today's Pharmaceutical Executive Daily, FDA's advisory committee votes in favor of Replimune's RP1 efficacy data in advanced melanoma, three clini…
3 months, 2 weeks ago
Pharmaceutical Executive Daily: Inizio Engage launches Connected Insights
In today's Pharmaceutical Executive Daily, Johnson & Johnson, Processa Pharmaceuticals, and Relation strike new deals spanning cell therapy, BTK inhi…
3 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves Viatris's Gwyn Lo
In today's Pharmaceutical Executive Daily, a commentary examines why fragmented software tooling causes scientific judgment to get lost across the bi…
3 months, 2 weeks ago